WEST PHARMACEUTICAL SERVICES INC (WST)
NYSE • Healthcare
Last close at July 2, 2026 at 20:00 UTC
Fundamentals Charts
About WEST PHARMACEUTICAL SERVICES INC
West Pharmaceutical Services, Inc. (NYSE: WST) makes containment and delivery products for injectable medicines and related healthcare uses, operating in the medical instruments and supplies business. The company generated $3.1 billion in FY2025 revenue. Its business centers on components for injectable packaging, advanced drug administration systems, and contract-made medical devices.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
WEST PHARMACEUTICAL SERVICES INC's Technical Indicators Summary
WST at about $365.74 is well above its short-, medium- and long-term moving averages, and ADX indicates a strengthening trend. Momentum readings are robust — MACD and CCI are strongly positive and momentum is elevated — while several overbought oscillators flag extended conditions. On-balance volume supports the move, and ATR shows moderate volatility versus price. The classic pivot sits slightly below current levels, which underscores recent strength. Technical takeaway: Strong Buy.
| Indicator | Value |
|---|---|
RSI (14) | 78.96 |
Stochastic %K (14, 3, 3) | 97.57 |
CCI (20) | 162.41 |
WPR (14) | -4.20 |
Momentum (10) | 42.15 |
MFI | 88.82 |
MACD Level (12, 26) | 12.94 |
Bollinger Bands | $306.26 - $367.46 |
ATR (14) | $8.39 (2.29%) |
ADX (14) | 29.64 |
OBV | 9,976,023 |
Classic Pivot Point | $361.78 |
Fibonacci Pivot Point | $361.78 |
Simple Moving Averages | $275.98 - $347.63(5 indicators) |
Exponential Moving Averages | $282.12 - $350.70(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day concluded with WST hovering close to the prior 365.00, holding a tiny 0.18% gap. The day wrapped with modest participation in WST, as overall volume reached only 0.43× average. WST ends roughly near its prior close on light volume as West Pharmaceutical completes the SmartDose sale to AbbVie.
Trading Volume
0
vs S&P 500 Today
Outperforming Market
+0.97%
52-Week Position
Near highs
98.8%
Updated: July 2, 2026 at 20:13 UTC
Quote Summary
WST Headlines
DACH-Focused Stock Moves Across Key Sectors
March 21, 2026